[
  {
    "ts": "2026-02-03T00:00:00+00:00",
    "headline": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
    "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
      "content": {
        "id": "944ac714-6d5e-3cf9-ac3d-5262ebfd6519",
        "contentType": "VIDEO",
        "title": "AMD earnings, Netflix-Warner Bros. hearing: What to Watch",
        "description": "<p>Market Domination Overtime Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Chipotle Mexican Grill (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/CMG\">CMG</a>), Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), and Merck (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/MRK\">MRK</a>), and the Senate hearing on Netflix's (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>) proposed bid to acquire Warner Bros. Discovery (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>).</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime Host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, February 3, including earnings results from companies like Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG), Pfizer (PFE), and Merck (MRK), and the Senate hearing on Netflix's (NFLX) proposed bid to acquire Warner Bros. Discovery (WBD). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2026-02-03T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UzqQCDUXj0MPW_tlpZ7E0A--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n0CeAGm.cJ44Rdq8zCs3Mw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/67792e30-0073-11f1-bfff-3c4891fc6d0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-earnings-netflix-warner-bros-000000934.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NFLX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:54:26+00:00",
    "headline": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
    "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
    "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
      "content": {
        "id": "a0b6e7e9-464d-36f0-b72d-7146e5449f6a",
        "contentType": "STORY",
        "title": "C4 Therapeutics, Inc. (CCCC): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on C4 Therapeutics, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on CCCC. C4 Therapeutics, Inc.’s share was trading at $1.9600 as of January 29th. C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins, stands at the forefront of targeted protein […]",
        "pubDate": "2026-02-03T01:54:26Z",
        "displayTime": "2026-02-03T01:54:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1",
          "originalWidth": 949,
          "originalHeight": 505,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qbitK_60Vc8oncBc9nQEQw--~B/aD01MDU7dz05NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 949,
              "height": 505,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wtjhuWw_GHJ65_98O46.rg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/91d6221e3df11e4933938a3082c41da1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/c4-therapeutics-inc-cccc-bull-015426512.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CCCC"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T01:08:48+00:00",
    "headline": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
    "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
    "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
      "content": {
        "id": "683c5af6-c445-3335-a02d-e524c12dc7cb",
        "contentType": "STORY",
        "title": "Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story",
        "description": "",
        "summary": "Pfizer, NYSE:PFE, has entered a global licensing agreement with Novavax to use Matrix-M adjuvant technology in the development of up to two infectious disease vaccines. The deal grants Pfizer non-exclusive worldwide rights and immediate control over research, development, and commercialization for these Matrix-M based candidates. Financial terms include an upfront payment, potential future milestone payments, and tiered royalties linked to product sales. Pfizer comes into this agreement...",
        "pubDate": "2026-02-03T01:08:48Z",
        "displayTime": "2026-02-03T01:08:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-taps-novavax-matrix-m-010848329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T00:32:25+00:00",
    "headline": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
    "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
      "content": {
        "id": "a22dfa67-759e-3c66-935d-83fff69c29ca",
        "contentType": "STORY",
        "title": "Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.’s share was trading at $4.18 as of January 30th. Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the […]",
        "pubDate": "2026-02-03T00:32:25Z",
        "displayTime": "2026-02-03T00:32:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2",
          "originalWidth": 749,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iLXPnbLixgbu7HLg88EG3A--~B/aD02MDA7dz03NDk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 749,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FUe6qiNfEaOYihq26Oq6OQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5e8b993356cd39a665654ae73d6f21b2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-003225191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACHV"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GSK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]